PPHM

QualityStocks: QualityStocks News - Peregrine Pharmaceuticals, Inc. (PPHM) Receives New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies - 11/25/08 - 11/27 - 04:04 AM ET

Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies - 11/25 - 08:00 AM ET

Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections - 11/24 - 07:45 AM ET

PPHM: To Present At Rodman & Renshaw Investment Conference @ 14:00 ET [delayed] - 11/11 - 12:23 PM ET

Peregrine Pharmaceuticals to Present at the Rodman & Renshaw 10th Annual Healthcare Conference - 11/05 - 08:00 AM ET

PPHM: To Present At BIO Investor Conference @ 18:45 ET [delayed] - 10/30 - 03:53 PM ET

Peregrine Pharmaceuticals to Present at BIO Investor Forum 2008 - 10/28 - 08:00 AM ET

Avid Bioservices to Serve as Contract Manufacturer for Catalyst Biosciences' Novel Human Coagulation Factor Clinical Candidate - 10/27 - 08:00 AM ET

Peregrine completes enrollment in first stage of Phase II lung cancer trial - 10/20 - 10:33 AM ET

PPHM: Completes Enrollment for Ph II Trial of Bavituximab in Lung Cancer - 10/20 - 09:15 AM ET

Peregrine Pharmaceuticals Completes Patient Enrollment In First Stage of Bavituximab Phase II Lung Cancer Trial - 10/20 - 08:00 AM ET

Peregrine Pharmaceuticals' anti-PS Technology Platform to Be Discussed at AIDS Vaccine 2008 Conference - 10/13 - 07:00 AM ET

Peregrine completes enrollment in first stage of Phase II cancer trial - 10/08 - 07:08 AM ET

Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial - 10/07 - 07:00 AM ET

Nasdaq Panel Grants Peregrine Pharmaceuticals' Request for 180-Day Extension for Continued Listing on Nasdaq - 09/17 - 07:00 AM ET

Peregrine Pharmaceuticals Report Earnings per Share Treading Water, Article Posted on BeaconEquity.com - 09/10 - 01:09 PM ET

Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2009 - 09/09 - 07:00 AM ET

Peregrine Pharmaceuticals to Report First Quarter FY 2009 Financial Results - 09/03 - 07:00 AM ET

Peregrine Pharmaceuticals begins dosing in Phase II trial of bavituximab - 08/13 - 10:59 AM ET

PPHM: Begins Ph II Trial of Bavituximab for Advanced Breast Cancer - 08/11 - 09:20 AM ET

Page 1 of 8     1  2   3   4   5   >   >>|     Previous  |  Next

<< Back to Stock Index